Acorah Software Products - Accounts Production15.0.600falsetruefalsetrueNo description of principal activity1 October 202330 September 202430 September 202414370475Mr Catalin-Leonard Popaiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure143704752023-09-30143704752024-09-30143704752023-10-012024-09-3014370475frs-core:CurrentFinancialInstruments2024-09-3014370475frs-bus:PrivateLimitedCompanyLtd2023-10-012024-09-3014370475frs-bus:FilletedAccounts2023-10-012024-09-3014370475frs-bus:Micro-entities2023-10-012024-09-3014370475frs-bus:AuditExempt-NoAccountantsReport2023-10-012024-09-3014370475frs-bus:Director12023-10-012024-09-30
Registered number: 14370475
Blockgain Labs Ltd
Unaudited Financial Statements
For The Year Ended 30 September 2024
Blockgain Labs Ltd
Balance Sheet
As At 30 September 2024
Balance Sheet
Registered number: 14370475
2024
£
Current assets
4,936
Creditors: Amounts Falling Due Within One Year
(2,302)
NET CURRENT ASSETS
2,634
TOTAL ASSETS LESS CURRENT LIABILITIES
2,634
Accruals and deferred income
(600)
NET ASSETS
2,034
CAPITAL AND RESERVES
2,034
Notes
1.General Information
Blockgain Labs Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14370475. The registered office is 107 Lyndhurst Avenue, Twickenham, Middlesex, TW2 6BH.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.